Home›Stock Screener›Zenlabs Ethica›Intrinsic Value

Zenlabs Ethica Intrinsic Value

Zenlabs Ethica intrinsic value. Zenlabs Ethica (ZENLABS) median intrinsic value is ₹52.62 from 3 valuation models (range ₹13–₹66), vs current price ₹26.31 — +100.0% upside (Trading Below Calculated Value), margin of safety 50.0%. For current market price and key ratios, visit ZENLABS share price.

Market Price (CMP)
₹26.31
Primary Intrinsic Value
₹12.86
Market Cap
₹18.4 Cr
+100.0% Upside
Median Value
₹52.62
Value Range
₹13 - ₹66
Assessment
Trading Below Calculated Value
Safety Margin
50.0%

ZENLABS Valuation Methods Summary — DCF, Graham Number & P/E

Zenlabs Ethica intrinsic value across 3 models vs current price ₹26.31 — upside/downside and value range per method. Analyse ZENLABS promoter holding to track promoter, FII and institutional holdings.

Method Type Intrinsic Value Range Upside/Downside Details
Book Value Method asset ₹12.86 ₹11.57 - ₹14.15 -51.1% Book Value/Share: ₹12.86, P/B: 1.0x
Revenue Multiple Method revenue ₹52.62 ₹47.36 - ₹57.88 +100.0% Revenue/Share: ₹70.00, P/S: 0.8x
Simple DCF (5Y) dcf ₹65.77 ₹52.62 - ₹78.92 +150.0% CF Growth: 15.0%, Discount: 15%
Method Types: Earnings Asset DCF Growth Dividend Conservative

ZENLABS Intrinsic Value vs Market Price — All Valuation Models

Zenlabs Ethica fair value range ₹13–₹66 vs current market price ₹26.31 across 3 valuation models. Browse Zenlabs Ethica financial data for revenue, profit, balance sheet and cash flow data.

ZENLABS Intrinsic Value Analysis — Undervalued or Overvalued?

Zenlabs Ethica median intrinsic value ₹52.62, current price ₹26.31 — Trading Below Calculated Value by 100.0%, margin of safety 50.0%.

What is the intrinsic value of ZENLABS?

Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Zenlabs Ethica (ZENLABS) is ₹52.62 (median value). With the current market price of ₹26.31, this represents a +100.0% variance from our estimated fair value.

The valuation range spans from ₹12.86 to ₹65.77, indicating ₹12.86 - ₹65.77.

Is ZENLABS undervalued or overvalued?

Based on our multi-method analysis, Zenlabs Ethica (ZENLABS) appears to be trading below calculated value by approximately 100.0%.

ZENLABS Financial Health — Key Ratios vs Industry Benchmarks

Zenlabs Ethica financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Return on Equity -33.3% Industry Standard: 15%+ Below 10% Measures shareholder return efficiency
Operating Margin -3.0% Industry Standard: 20%+ Below 10% Indicates operational efficiency level
Asset Turnover Ratio 1.32x Industry Standard: 1.0x+ Above 1.0x Measures asset utilization efficiency

ZENLABS Cash Flow Quality — Operating & Free Cash Flow

Zenlabs Ethica operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2026 ₹4 Cr ₹4 Cr Positive Free Cash Flow 8/10
March 2025 ₹4 Cr ₹4 Cr Positive Free Cash Flow 8/10
March 2024 ₹-9 Cr ₹-9 Cr Negative Cash Flow 3/10
March 2023 ₹2 Cr ₹1 Cr Positive Free Cash Flow 7/10
March 2022 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10